Professor Li Chi Kong

Personal Information

Professor Li Chi Kong

M.B, BS,MRCP(UK), DCH(London), FHKCPaed, FHKAM(Paed), Diploma in Epidemiology & Applied Statistics (CUHK), FRCPCH(UK), Doctor of Medicine(CUHK)

mail :


Dr. CK Li graduated from the University of Hong Kong in 1981. He completed general paediatric training at Hong Kong and then specialised in paediatric Haematology/oncology/BMT, with further training at John Radcliff Hospital, Oxford, and Great Ormond Street Hospital, London in 1986, and Fred Hutchison Cancer Research Centre, Seattle in 1992. Dr. Li joined PWH in 1989 as Senior Medical Officer and became consultant in 1993, and is now professor. Currently he is also honorary professor in 3 medical universities in China. His main interest is in childhood leukaemia, haematopoietic stem cell transplantation and thalassaemia. He is the study chair for acute lymphoblastic leukaemia trials in Hong Kong and also local coordinators for several international multicenter studies. He introduced the new treatment methods for Hong Kong children including double unit umbilical cord blood transplantation, MIBG treatment for neuroblastoma. Dr. Li also actively involves in the development of paediatric oncology in mainland China. He is vice chairman of China Children Cancer Group, and vice-chairman of steering committee for two consecutive multi-center leukaemia studies in China. Currently he is the President of Asia Continent of International Society of Pediatric Oncology. In recent years he also actively involved in the development of children’s palliative care in Hong Kong and mainland China. He has published over 300 peer-reviewed papers, written chapters in 4 books and editor of one book. He also serves as editors in medical journals including Pediatric Blood Cancer, Chinese Journal of Pediatrics, China Journal of Pediatric Hematology & Oncology.

Current appointments

  • Professor; Chief, Division of Haematology/Oncology/BMT, Department of Paediatrics, The Chinese University of Hong Kong

  • Honorary Consultant, Departments of Paediatrics, Prince of Wales Hospital,Hong Kong

  • Member, Governing Committee, Hong Kong Red Cross Blood Transfusion Service, Hospital Authority.

  • Chairman, Clinical Research Management Committee, CUHK-NTEC, Hospital Authority.

  • Board Member, Hong Kong Marrow Match Foundation.

  • Board member, Hong Kong Children’s Thalassaemia Foundation

  • Continental President of Asia, The International Society of Pediatric Oncology.

  • Executive Board Member, International BFM Study Group (Childhood Leukemia ) (since 2000)

  • Vice-Chairman, The China Children Cancer Group

  • Council Member, Hong Kong College of Paediatricians

  • Chairman, Hong Kong Society of Children’s Palliative Care

  • Trustee, Butterfly Children’s Hospice, China.

  • Member, Governing Committee, Children’s Palliative Care Foundation, Hong Kong.  

  • Member, Barristers Disciplinary Tribunal Panel, Hong Kong.


Previous appointments and awards

  • Justice of Peace, HKSAR

  • Member, Hospital authority (2012 – 2015)

  • Chairman, Coordinating Committee in Paediatrics, Hospital Authority, Hong Kong (since 2010 – 2015)

  • Chairman, Clinical Ethics Committee, NTE Cluster, Hospital Authority. (2003 – 2016)

  • Deputy Chairman, CUHK-NTEC Clinical Research Ethics Committee (2002 – 2016)

  • Chairman, Hong Kong Paediatric Haematology & Oncology Study Group (1995-1997)

  • Member, Committee of Establishing a Central Cord Blood Bank at HKRCBTS

  • Vice-Chairman, Haematology Committee, The Chinese Pediatric Association, China (2007 – 2013)


Research Interests

  • Chairman, Hong Kong Acute Lymphoblastic Leukaemia 93 Study (1993-1997), 97 Study (1997-2002), 2002 (2002-2008)

  • Hong Kong Co-ordinator, Interfant (International Infant Acute Lymphoblastic Leukaemia) 99 Study, 2006 study

  • Hong Kong Coordinator, ESPhALL Study: (Ph+ALL)

  • Vice-Chairman, Chinese Childhood Leukaemia Group ALL 2008 Study (2008 – 2015)

  • Vice-Chairman, Steering Committee, Chinese Children Cancer Group ALL 2015 (2015- )

Recent Publications: over 300 peer-reviewed papers

1.     Cui L, Li ZG, Chai YH, Yu J, Gao J, Zhu XF, Jin RM, Shi XD, Zhang LP, Gao YJ, Zhang RD, Zheng HY, Hu SY, Cui YH, Zhu YP, Zou Y, Ng MHL, Xiao Y, Li JH, Zhang YH, He HL, Xian Y, Wang TY, Li CK, Wu MY; Chinese Children Leukemia Group(CCLG).Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG-ALL 2008: The first nation-wide prospective multicenter study in China. Am J Hematol. 2018 Apr 20. doi: 10.1002/ajh.25124. [Epub ahead of print]

2.     Millot F, Guilhot J, Suttorp M, Güneş AM, Sedlacek P, De Bont E, Li CK, Kalwak K, Lausen B, Culic S, Dworzak M, Kaiserova E, De Moerloose B, Roula F, Biondi A, Baruchel A. Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents. Haematologica. 2017 Oct;102(10):1704-1708

3.     Chan MCW, Cheng FWT, Sze KH, Wong AH, Leung AWK, Chan PKS, Li CK.  Hepatitis B infection acquired after haematopioetic stem cell transplant through horizontal mode.  Journal of Medical Virology, 2017; Apr 29. doi: 10.1002/jmv.24835

4.     Chow TW, Leung WK, Cheng FWT, Kumta SM, Chu WCW, Lee V, Shing MMK, Li CK.  Late outcomes in children with Langerhans Cell Histiocytosis.  Arch Dis Child. 2017 Sep;102(9):830-835.

5.     Li CK.  New trend in the epidemiology of thalassaemia.  Best Practice & Research Clinical Obstetrics & Gynaecology, 2017; 39:16-26.

6.     Lam GK, Leung AW, Ha SY, Luk CW, Li CH, Ling SC, Chiang AK, Li CK.  Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.  J Pediatr Hematol Oncol. 2016 Mar;38(2):102-6.

7.     Tsang KS, Leung AWK, Lee V, Cheng FWT, Shing MMK, Pong HNH, Leung TF, Yuen PMP, Li CK.  Indiscernible Benefit of Double-Unit Umbilical Cord Blood Transplantation in Children:  A Single-center Experience from Hong Kong.  Cell Transplant. 2016;25(7):1277-86.

8.     Driessen EM, de Lorenzo P, Campbell M, Felice M, Ferster A, HannI, Hovi L, Escherich G, Li CK, Mann G, Leblanc T, Locatelli F, Biondi A, Rubnitz J, Schrappe M, Silverman L, Stary J, Suppiah R, Szczepanski T, Valsecchi M, Pieters R.  Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.  Leukemia. 2016 May;30(5):1184-7

9.     Wong FCK, Leung AWK, Kwok JSS, Chan MHM, Li CK, Yuen YP.  NUDT15 variant and thiopurine-induced leukopenia in Hong Kong.  Hong Kong Medical Journal, 2016; 22(2):185-187.

10.  Zheng C, Luan Z, Fang J, Sun X, Chen J, Li CK, Hu S, Zhu Y, Sun Z.  Comparison of conditioning regimens with or without antithymocyte globulin for unrelated cord blood transplantation in children with high-risk or advanced hematological malignancies.  Biol Blood Marrow Transplant. 2015 Apr; 21(4):707-12.


Faculty of Medicine

The Chinese University of Hong Kong

6/F Lui Che Woo Clinical Sciences Building

Prince of Wales Hospital



Office Hours:

08:45 - 13:00 and 14:00 - 17:30 (Mon - Thur)

08:45 - 13:00 and 14:00 - 17:45 (Fri)


Tel:       +852 3505-2851

Fax:      +852 2636-0020

Copyright © 2018.

All Rights Reserved.

The Chinese University of Hong Kong.

  • Instagram Social Icon
  • Facebook Social Icon